In addition, preoperative radiochemotherapy may induce overexpression of PD-L1 mediated by activated TILs via the explosive release of tumor-associated molecules (TAMs), which indicates that identification or development of strict inclusion criteria should be put on the agenda. The gene discussed is CD274; the disease is neoplasm.